This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignees: The University of Tokyo, Yamaguchi University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,358 
1 out of 89 Years Active: 2026
Title: Kohei Miyazono: Innovator in Brain Tumor Research
Introduction
Kohei Miyazono is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medical research, particularly in the area of brain tumors. His innovative work has led to the development of a patent that addresses critical issues in glioma treatment and prognosis.
Latest Patents
Miyazono holds a patent titled "Therapeutic and Prophylactic Agent for Glioma, Brain Tumor Malignancy Marker, Brain Tumor Prognostic Marker, Method for Determining Malignancy and Prognosis of Brain Tumor and Antibody Inhibiting Tumor Proliferation." This patent represents a significant advancement in the understanding and treatment of brain tumors, showcasing his dedication to improving patient outcomes.
Career Highlights
Throughout his career, Kohei Miyazono has worked at esteemed institutions such as The University of Tokyo and Yamaguchi University. His research has focused on developing innovative solutions for complex medical challenges, particularly in oncology.
Collaborations
Miyazono has collaborated with notable professionals in his field, including Ryo Tanabe. These partnerships have further enhanced his research and contributed to the advancement of medical science.
Conclusion
Kohei Miyazono's work in brain tumor research exemplifies the impact of innovation in medicine. His patent and collaborations reflect a commitment to improving the lives of patients affected by gliomas.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile